Georgetown University - Lombardi Comprehensive Cancer Center - 1134847 is a clinical research site located in Washington D.C., District of Columbia, United States 20007.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Georgetown University - Lombardi Comprehensive Cancer Center - 1134847 has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Solid Tumors, Gastric Cancer, Non-Small Cell Lung Cancer (NSCLC).
Sponsors: EMD Serono Research & Development Institute, Inc..
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Georgetown University - Lombardi Comprehensive Cancer Center - 1134847 has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Georgetown University - Lombardi Comprehensive Cancer Center - 1134847 has 1 clinical trials on record, with 1 currently active. Their work covers Solid Tumors, Gastric Cancer, Non-Small Cell Lung Cancer (NSCLC).
Georgetown University - Lombardi Comprehensive Cancer Center - 1134847 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.